Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	62.24	73.61	45.37
Graham Fair Price	40.90	3.37	2.39
PEG	125.42	-6.47	2.87
Price/Book	2.03	3.82	3.74
Price/Cash Flow	71.11	-82.69	48.33
Prices/Earnings	5.48	-299.96	-317.35
Price/Sales	37.52	7.72	5.62
Price/FCF	71.11	-82.69	48.33
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-63.22	0.03	0.07
Operating Margin	-63.22	0.03	0.07
ROA	-45.24	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-7.95
ROIC	0.02	0.01	-44.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	-0.03	-22.69
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.28	-0.62	-121.58
EPS QOQ	-1.11	-0.46	58.07
FCF QOQ	5.93	-1.83	-69.23
Revenue QOQ	0.05	0.03	-41.20
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-7.31
Days Sales Outstanding (DSO)	40.47	46.67	15.30
Inventory Turnover	389278000.00	419957000.00	7.88
Debt/Capitalization	0.58	0.51	-13.45
Quick Ratio	1.22	1.75	44.39
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9.29	12.60	35.61
Cash	5.04	7.60	50.72
Capex	-0.59	-0.83	-40.40
Free Cash Flow	0.72	-0.58	-19.13
Revenue	6.19	6.23	0.62
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.32	1.86	40.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.85	16.93	14.04
Naive Interpretation	Member

06 - Financial Health · Weak

Rating